Octreotide

Cholelithiasis and vomiting following off-label use: 2 case reports

    This is a preview of subscription content, log in to check access.

    Notes

    1. 1.

      Identifying patient details (sex) and year of birth have been obtained through direct communication with the author.

    Reference

    1. Hrachova M, et al. A Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR for Treatment of Recurrent and/or Refractory Meningiomas. Frontiers in Neurology 11: 373, 6 May 2020. Available from: URL: http://doi.org/10.3389/fneur.2020.00373

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Octreotide. Reactions Weekly 1810, 167 (2020). https://doi.org/10.1007/s40278-020-80187-y

    Download citation